Home Tarveda Therapeutics

Tarveda Therapeutics

In operation
-
Oncology Drug Research, Development, and Manufacturing

Basic Information

Tarveda's mission is to discover, develop and commercialize a new class of potent, selective precision oncology drugs for the treatment of various solid tumor malignancies. Tarveda has developed its Pentarin mini-drug conjugates to enhance the effectiveness of anti-cancer payloads by selectively targeting them to solid tumors.
Tarveda Therapeutics, Inc.
Massachusetts,United States of America
15~50 people
January 01, 2011
info@tarveda.com